Page last updated: 2024-10-21

s,s'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea and Colonic Neoplasms

s,s'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea has been researched along with Colonic Neoplasms in 3 studies

S,S'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea: structure in first source

Colonic Neoplasms: Tumors or cancer of the COLON.

Research Excerpts

ExcerptRelevanceReference
" Previously, we showed that the selective iNOS inhibitor S,S'-1,4-phenylenebis(1,2-ethanediyl)bis-isothiourea (PBIT) caused significant inhibition of colon carcinogenesis induced by azoxymethane (AOM), although it did not completely abrogate NO production due to the exogenous bioavailability of NO and NO generation by eNOS in tumor tissues."1.39Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats. ( Amin, S; Choi, CI; Desai, D; Janakiram, NB; Mohammed, A; Rao, CV; Ravillah, D; Zhang, Y, 2013)
"Malignant melanoma is the most deadly form of skin cancer due to its highly metastatic nature."1.35PBISe, a novel selenium-containing drug for the treatment of malignant melanoma. ( Amin, S; Desai, D; Huh, SJ; Madhunapantula, SV; Robertson, GP; Sharma, A, 2008)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janakiram, NB1
Mohammed, A1
Ravillah, D1
Choi, CI1
Zhang, Y1
Desai, D2
Amin, S2
Rao, CV2
Madhunapantula, SV1
Sharma, A1
Huh, SJ1
Robertson, GP1
Kawamori, T1
Hamid, R1
Reddy, BS1

Other Studies

3 other studies available for s,s'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea and Colonic Neoplasms

ArticleYear
Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats.
    Oncology reports, 2013, Volume: 30, Issue:2

    Topics: Aberrant Crypt Foci; Animals; Apoptosis; Azoxymethane; Caco-2 Cells; Cell Line, Tumor; Cell Prolifer

2013
PBISe, a novel selenium-containing drug for the treatment of malignant melanoma.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Prolifer

2008
Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
    Carcinogenesis, 1999, Volume: 20, Issue:4

    Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogens; Colonic Diseases; Colonic Neoplasms; Cu

1999